Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,344 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Thyroid dermopathy responds to teprotumumab therapy.
Crespo-Trevino R, Schiffman J, Ugradar S, Cockerham K, Douglas R, de Leon-Garza D, Tang R. Crespo-Trevino R, et al. Among authors: tang r. Endocrinol Diabetes Metab Case Rep. 2022 Mar 1;2022:21-0201. doi: 10.1530/EDM-21-0201. Online ahead of print. Endocrinol Diabetes Metab Case Rep. 2022. PMID: 35319490 Free PMC article.
Teprotumumab for the Treatment of Active Thyroid Eye Disease.
Douglas RS, Kahaly GJ, Patel A, Sile S, Thompson EHZ, Perdok R, Fleming JC, Fowler BT, Marcocci C, Marinò M, Antonelli A, Dailey R, Harris GJ, Eckstein A, Schiffman J, Tang R, Nelson C, Salvi M, Wester S, Sherman JW, Vescio T, Holt RJ, Smith TJ. Douglas RS, et al. Among authors: tang r. N Engl J Med. 2020 Jan 23;382(4):341-352. doi: 10.1056/NEJMoa1910434. N Engl J Med. 2020. PMID: 31971679 Clinical Trial.
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X Study.
Douglas RS, Kahaly GJ, Ugradar S, Elflein H, Ponto KA, Fowler BT, Dailey R, Harris GJ, Schiffman J, Tang R, Wester S, Jain AP, Marcocci C, Marinò M, Antonelli A, Eckstein A, Führer-Sakel D, Salvi M, Sile S, Francis-Sedlak M, Holt RJ, Smith TJ. Douglas RS, et al. Among authors: tang r. Ophthalmology. 2022 Apr;129(4):438-449. doi: 10.1016/j.ophtha.2021.10.017. Epub 2021 Oct 21. Ophthalmology. 2022. PMID: 34688699 Free article. Clinical Trial.
Teprotumumab for Thyroid-Associated Ophthalmopathy.
Smith TJ, Kahaly GJ, Ezra DG, Fleming JC, Dailey RA, Tang RA, Harris GJ, Antonelli A, Salvi M, Goldberg RA, Gigantelli JW, Couch SM, Shriver EM, Hayek BR, Hink EM, Woodward RM, Gabriel K, Magni G, Douglas RS. Smith TJ, et al. Among authors: tang ra. N Engl J Med. 2017 May 4;376(18):1748-1761. doi: 10.1056/NEJMoa1614949. N Engl J Med. 2017. PMID: 28467880 Free PMC article. Clinical Trial.
Retinal toxicity secondary to Plaquenil therapy.
Hanna B, Holdeman NR, Tang RA, Schiffman JS. Hanna B, et al. Among authors: tang ra. Optometry. 2008 Feb;79(2):90-4. doi: 10.1016/j.optm.2007.08.017. Optometry. 2008. PMID: 18215798
Optical Coherence Tomography for the Radiologist.
Schiffman JS, Patel NB, Cruz RA, Tang RA. Schiffman JS, et al. Neuroimaging Clin N Am. 2015 Aug;25(3):367-82. doi: 10.1016/j.nic.2015.05.002. Neuroimaging Clin N Am. 2015. PMID: 26208414 Review.
Telemedicine enters eye care: practical experience.
Schiffman JS, Li HK, Tang RA. Schiffman JS, et al. Among authors: tang ra. J Ophthalmic Nurs Technol. 1998 May-Jun;17(3):102-6. J Ophthalmic Nurs Technol. 1998. PMID: 9677981 Review.
5,344 results